Y-Intercept (HK)’s Atara Biotherapeutics ATRA Stock Holding History

Y-Intercept (HK)’s Portfolio ATRA Stock Details ATRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,987	Closed	-$160K	–	1055
2023 Q2	$160K	Buy	+3,987	New	+$225K	0.02%	973
2023 Q1	–	Sell	-753	Closed	-$61.7K	–	1167
2022 Q4	$61.7K	Buy	+753	New	+$78.5K	0.01%	910

Other funds holding ATRA

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Y-Intercept (HK)'s ATRA Position: Q3 2023 in Review

Y-Intercept (HK) sold out of Atara Biotherapeutics (ATRA) in Q3 2023, closing a stake of 3,987 shares — an estimated $160K sold.

Y-Intercept (HK) first reported a position in ATRA in Q4 2022 and held it in 2 quarters. The position peaked at $160K in Q2 2023. 109 funds tracked by Wall St. Rank hold ATRA as of Q3 2023.

Y-Intercept (HK) reported no remaining Atara Biotherapeutics position as of Q3 2023 after selling out during the quarter.
Y-Intercept (HK) sold 3,987 Atara Biotherapeutics shares in Q3 2023, an estimated $160K.
Y-Intercept (HK) first reported a position in Atara Biotherapeutics in Q4 2022 and held it in 2 quarters.
Y-Intercept (HK)'s Atara Biotherapeutics position peaked at $160K in Q2 2023.
109 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q3 2023.

Based on Y-Intercept (HK)'s 13F filing for Q3 2023, filed 14 Nov 2023.